Brief Description
Sift Biosciences supercharges existing cancer therapies by leveraging artificial intelligence and high-throughput cellular screening to discover and design immunotherapy boosters that significantly extend cancer patient survival. The company was co-founded by Yue Clare Lou (BS ’18 Microbial Biology; PhD ’23 Microbiology) and Maddie Williams (PhD student '23-present, Molecular & Cell Biology) to commercize technology developed during their doctoral research at UC Berkeley.
Inventors
Yue "Clare" Lou, Madeline Dee Williams
Company Founders
Yue "Clare" Lou (UC Berkeley BA, 2018, PhD, 2023, Microbiology), Madeline Dee Williams
Timeline
- 2024. Company founded